|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ATNX
|
Athenex, Inc.
|
US
|
NASDAQ
|
|
BNTC
|
Benitec Biopharma Limited
|
US
|
NASDAQ
|
|
BYSI
|
BeyondSpring, Inc.
|
US
|
NASDAQ
|
|
CADL
|
Candel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CCM
|
Concord Medical Services Holdings Limited ADS
|
US
|
NYSE
|
|
CHRS
|
Coherus BioSciences, Inc.
|
US
|
NASDAQ
|
|
CKPT
|
Checkpoint Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
DBTX
|
Decibel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DCTH
|
Delcath Systems, Inc.
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ICUI
|
ICU Medical, Inc.
|
US
|
NASDAQ
|
|
INDP
|
Indaptus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
INFU
|
InfuSystems Holdings, Inc.
|
US
|
AMEX
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
US
|
NASDAQ
|
|
KZIA
|
Kazia Therapeutics Limited
|
US
|
NASDAQ
|